Press coverage about Orthopediatrics (NASDAQ:KIDS) has trended positive recently, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Orthopediatrics earned a news sentiment score of 0.29 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.2578730854438 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the headlines that may have impacted Accern Sentiment’s analysis:
- Orthopediatrics Corp (KIDS) Director David R. Pelizzon Purchases 1,000 Shares (americanbankingnews.com)
- Brokers Set Expectations for Orthopediatrics Corp’s Q1 2019 Earnings (KIDS) (americanbankingnews.com)
- Head-To-Head Contrast: Stryker (SYK) versus Orthopediatrics (KIDS) (americanbankingnews.com)
- OrthoPediatrics reports 4Q loss (finance.yahoo.com)
- Orthopediatrics (KIDS) Posts Earnings Results (americanbankingnews.com)
Shares of Orthopediatrics (KIDS) traded up $0.34 during midday trading on Wednesday, reaching $17.60. The company’s stock had a trading volume of 14,320 shares, compared to its average volume of 40,644. The company has a debt-to-equity ratio of -0.38, a quick ratio of 1.00 and a current ratio of 2.78. Orthopediatrics has a 52 week low of $15.10 and a 52 week high of $23.00.
Orthopediatrics Company Profile
OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.